Ruhi Nath
Program Manager, Dunlevie Maternal-Fetal Medicine Center for Discovery, Innovation and Clinical Impact
All Publications
-
Differentiating the roles of STAT5B and STAT5A in human CD4(+) T cells
CLINICAL IMMUNOLOGY
2013; 148 (2): 227-236
Abstract
STAT5A and STAT5B are highly homologous proteins whose distinctive roles in human immunity remain unclear. However, STAT5A sufficiency cannot compensate for STAT5B defects, and human STAT5B deficiency, a rare autosomal recessive primary immunodeficiency, is characterized by chronic lung disease, growth failure and autoimmunity associated with regulatory T cell (Treg) reduction. We therefore hypothesized that STAT5A and STAT5B play unique roles in CD4(+) T cells. Upon knocking down STAT5A or STAT5B in human primary T cells, we found differentially regulated expression of FOXP3 and IL-2R in STAT5B knockdown T cells and down-regulated Bcl-X only in STAT5A knockdown T cells. Functional ex vivo studies in homozygous STAT5B-deficient patients showed reduced FOXP3 expression with impaired regulatory function of STAT5B-null Treg cells, also of increased memory phenotype. These results indicate that STAT5B and STAT5A act partly as non-redundant transcription factors and that STAT5B is more critical for Treg maintenance and function in humans.
View details for DOI 10.1016/j.clim.2013.04.014
View details for Web of Science ID 000322101300009
View details for PubMedID 23773921
View details for PubMedCentralID PMC4169138
-
Stat5b (Signal Transducer and Activator of Transcription 5b), Not Stat5a, Is a Critical Modulator of Human Treg Development and Function
Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)
MOSBY-ELSEVIER. 2012: AB10–AB10
View details for Web of Science ID 000301133400040